GlassScriptPhysician profile
Ravi Viradia
NPI 1922411628
$13,014.21
in general payments reported to CMS, 2019-2025
26 companies · $3,030 in 2025
The $3,030 reported for 2025 was more than what 89% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $762 · 2020: $717 · 2021: $1,788 · 2022: $2,805 · 2023: $1,243 · 2024: $2,670 · 2025: $3,030.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,646 · Travel and Lodging: $2,319 · Long Term Medical Supply Or Device Loan: $977.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,646.40 |
| Travel and Lodging | $2,318.59 |
| Long Term Medical Supply Or Device Loan | $977.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alpha Orthopedic Systems | $4,058.01 | 2020-2022 | |
| Stryker Corporation | $1,579.85 | 2020-2025 | 1788, Swanson, Variax |
| Tela Bio, INC. | $1,493.01 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Integra Lifesciences Corporation | $1,263.29 | 2024-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Mentor Worldwide LLC | $1,142.02 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Musculoskeletal Transplant Foundation INC. | $718.91 | 2025 | |
| Arthrex, INC. | $556.16 | 2023 | |
| Medical Device Business Services, INC. | $549.39 | 2024 | |
| Coastal Medical Technologies LLC | $227.76 | 2023 | |
| Axogen | $132.01 | 2021-2022 | |
| Baxter Healthcare | $125.45 | 2025 | Tisseel |
| Sanofi-Aventis U.S. LLC | $125.00 | 2019 | |
| Skeletal Dynamics INC | $117.65 | 2019 | |
| Novartis Pharmaceuticals Corporation | $115.00 | 2019 | |
| Endo Pharmaceuticals INC. | $111.22 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $97.00 | 2022 | |
| Allergan, INC. | $93.05 | 2021 | |
| Kci USA, INC. | $92.05 | 2019 | |
| Abbvie INC. | $90.04 | 2023-2025 | Alloderm |
| Globus Medical, INC. | $83.87 | 2022-2024 | Mini Fragment System, Distal Radius II |
| Teva Pharmaceuticals USA, INC. | $79.02 | 2019 | |
| Novo Nordisk INC | $70.98 | 2019 | |
| Ethicon US, LLC | $28.70 | 2025 | Vistaseal, Stratafix |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $26.22 | 2024 | |
| Biofrontera INC. | $20.66 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
| Mimedx Group, INC. | $17.89 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravi Viradia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.